$ZSAN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Zosano Pharma Corp.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Zosano Pharma Corp. Get notifications about new insider transactions in Zosano Pharma Corp for free.

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 14 2021	ZSAN	Zosano Pharma Corp	Hagan Joseph P	Director	Option Exercise	A	0.93	30,000	27,954	30,000
Jun 14 2021	ZSAN	Zosano Pharma Corp	Hagan Joseph P	Director	Grant	A	0.00	15,000	0	22,500	7.5 K to 22.5 K (+200.00 %)
Jun 14 2021	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G	Director	Option Exercise	A	0.93	30,000	27,954	30,000
Jun 14 2021	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G	Director	Grant	A	0.00	15,000	0	23,596	8.6 K to 23.6 K (+174.50 %)
Jun 07 2021	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Sell	S	0.81	1,709	1,376	50,337	52 K to 50.3 K (-3.28 %)
Jun 07 2021	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Sell	S	0.81	1,709	1,376	50,337	52 K to 50.3 K (-3.28 %)
Apr 01 2021	ZSAN	Zosano Pharma Corp	Lo Steven	Chief Executive Off ...	Option Exercise	A	1.20	465,000	558,000	465,000
Apr 01 2021	ZSAN	Zosano Pharma Corp	Lo Steven	Chief Executive Off ...	Grant	A	0.00	232,500	0	378,750	146.3 K to 378.8 K (+158.97 %)
Apr 01 2021	ZSAN	Zosano Pharma Corp	Lewis Hayley	See Remarks	Option Exercise	A	1.20	65,000	78,000	65,000
Apr 01 2021	ZSAN	Zosano Pharma Corp	Lewis Hayley	See Remarks	Grant	A	0.00	32,500	0	51,488	19 K to 51.5 K (+171.16 %)
Apr 01 2021	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Option Exercise	A	1.20	65,000	78,000	65,000
Apr 01 2021	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Grant	A	0.00	32,500	0	52,046	19.5 K to 52 K (+166.27 %)
Apr 01 2021	ZSAN	Zosano Pharma Corp	Matthews Christine	Chief Financial Off ...	Option Exercise	A	1.20	162,500	195,000	162,500
Apr 01 2021	ZSAN	Zosano Pharma Corp	Matthews Christine	Chief Financial Off ...	Grant	A	0.00	81,250	0	100,000	18.8 K to 100 K (+433.33 %)
Apr 01 2021	ZSAN	Zosano Pharma Corp	Lo Steven	Chief Executive Off ...	Option Exercise	A	1.20	465,000	558,000	465,000
Apr 01 2021	ZSAN	Zosano Pharma Corp	Lo Steven	Chief Executive Off ...	Grant	A	0.00	232,500	0	378,750	146.3 K to 378.8 K (+158.97 %)
Apr 01 2021	ZSAN	Zosano Pharma Corp	Lewis Hayley	See Remarks	Option Exercise	A	1.20	65,000	78,000	65,000
Apr 01 2021	ZSAN	Zosano Pharma Corp	Lewis Hayley	See Remarks	Grant	A	0.00	32,500	0	51,488	19 K to 51.5 K (+171.16 %)
Apr 01 2021	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Option Exercise	A	1.20	65,000	78,000	65,000
Apr 01 2021	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Grant	A	0.00	32,500	0	52,046	19.5 K to 52 K (+166.27 %)
Apr 01 2021	ZSAN	Zosano Pharma Corp	Matthews Christine	Chief Financial Off ...	Option Exercise	A	1.20	162,500	195,000	162,500
Apr 01 2021	ZSAN	Zosano Pharma Corp	Matthews Christine	Chief Financial Off ...	Grant	A	0.00	81,250	0	100,000	18.8 K to 100 K (+433.33 %)
Mar 19 2021	ZSAN	Zosano Pharma Corp	Lo Steven	Chief Executive Off ...	Option Exercise	A	1.37	450,000	616,500	450,000
Jun 29 2020	ZSAN	Zosano Pharma Corp	Hagan Joseph P		Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jun 29 2020	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH		Grant	A	0.00	7,500	0	17,500	10 K to 17.5 K (+75.00 %)
Jun 29 2020	ZSAN	Zosano Pharma Corp	Lo Steven	Chief Executive Off ...	Grant	A	0.00	146,250	0	146,250	0 to 146.3 K
Jun 29 2020	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G		Grant	A	0.00	7,500	0	8,596	1.1 K to 8.6 K (+684.31 %)
Jun 29 2020	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER		Grant	A	0.00	7,500	0	116,511	109 K to 116.5 K (+6.88 %)
Jun 29 2020	ZSAN	Zosano Pharma Corp	Lewis Hayley	See Remarks	Grant	A	0.00	18,750	0	18,988	238 to 19 K (+7,878.15 %)
Jun 29 2020	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Grant	A	0.00	18,750	0	19,546	796 to 19.5 K (+2,355.53 %)
Jun 29 2020	ZSAN	Zosano Pharma Corp	Matthews Christine	Chief Financial Off ...	Grant	A	0.00	18,750	0	18,750	0 to 18.8 K
Jun 29 2020	ZSAN	Zosano Pharma Corp	Grais Linda S		Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jun 29 2020	ZSAN	Zosano Pharma Corp	ELMS STEVE		Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jun 29 2020	ZSAN	Zosano Pharma Corp	Grais Linda S		Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jun 29 2020	ZSAN	Zosano Pharma Corp	ELMS STEVE		Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jun 05 2020	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Director	Option Exercise	A	1.01	15,000	15,150	15,000
Jun 05 2020	ZSAN	Zosano Pharma Corp	Lo Steven	Chief Executive Off ...	Option Exercise	A	1.01	292,500	295,425	292,500
Jun 05 2020	ZSAN	Zosano Pharma Corp	ELMS STEVE	Director	Option Exercise	A	1.01	15,000	15,150	15,000
Jun 05 2020	ZSAN	Zosano Pharma Corp	Grais Linda S	Director	Option Exercise	A	1.01	15,000	15,150	15,000
Jun 05 2020	ZSAN	Zosano Pharma Corp	Grais Linda S	Director	Option Exercise	A	1.01	15,000	15,150	15,000
Jun 05 2020	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G	Director	Option Exercise	A	1.01	15,000	15,150	15,000
Jun 05 2020	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH	Director	Option Exercise	A	1.01	15,000	15,150	15,000
Jun 05 2020	ZSAN	Zosano Pharma Corp	Hagan Joseph P	Director	Option Exercise	A	1.01	15,000	15,150	15,000
Jun 05 2020	ZSAN	Zosano Pharma Corp	Lewis Hayley	See Remarks	Option Exercise	A	1.01	37,500	37,875	37,500
Jun 05 2020	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Option Exercise	A	1.01	37,500	37,875	37,500
Jun 05 2020	ZSAN	Zosano Pharma Corp	Matthews Christine	Chief Financial Off ...	Option Exercise	A	1.01	37,500	37,875	37,500
Dec 06 2019	ZSAN	Zosano Pharma Corp	Aisling Capital IV, LP	10% Owner	Grant	A	1.45	689,655	1,000,000	2,718,226	2 M to 2.7 M (+34.00 %)
Oct 23 2019	ZSAN	Zosano Pharma Corp	Lo Steven	Chief Executive Off ...	Option Exercise	A	1.94	450,000	873,000	450,000
Jul 18 2019	ZSAN	Zosano Pharma Corp	Hagan Joseph P	Director	Option Exercise	A	2.34	1,500	3,510	1,500
Jul 18 2019	ZSAN	Zosano Pharma Corp	ELMS STEVE	Director	Option Exercise	A	2.34	1,500	3,510	1,500
Jul 18 2019	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH	Director	Option Exercise	A	2.34	1,500	3,510	1,500
Jul 18 2019	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G	Director	Option Exercise	A	2.34	1,500	3,510	1,500
Jul 18 2019	ZSAN	Zosano Pharma Corp	WILSON TROY EDWARD	Director	Option Exercise	A	2.34	1,500	3,510	1,500
Jun 13 2019	ZSAN	Zosano Pharma Corp	Kitchener Gregory David	Chief Financial Off ...	Option Exercise	A	2.75	45,000	123,750	45,000
Jun 13 2019	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Option Exercise	A	2.75	30,000	82,500	30,000
Jun 13 2019	ZSAN	Zosano Pharma Corp	Lewis Hayley	See Remarks	Option Exercise	A	2.75	30,000	82,500	30,000
Apr 18 2019	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	President & CEO	Buy	P	3.50	100,000	350,000	280,228	180.2 K to 280.2 K (+55.49 %)
Apr 12 2019	ZSAN	Zosano Pharma Corp	Aisling Capital IV, LP	10% Owner	Grant	A	3.50	428,571	1,499,999	2,028,571	1.6 M to 2 M (+26.79 %)
Jan 16 2019	ZSAN	Zosano Pharma Corp	Grais Linda S	Director	Option Exercise	A	2.56	25,000	64,000	25,000
Oct 16 2018	ZSAN	Zosano Pharma Corp	Kitchener Gregory David	Chief Financial Off ...	Option Exercise	A	3.93	100,000	393,000	100,000
Jun 01 2018	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G	Director	Option Exercise	A	4.24	25,000	106,000	25,000
Jun 01 2018	ZSAN	Zosano Pharma Corp	WILSON TROY EDWARD	Director	Option Exercise	A	4.24	25,000	106,000	25,000
Jun 01 2018	ZSAN	Zosano Pharma Corp	Hagan Joseph P	Director	Option Exercise	A	4.24	25,000	106,000	25,000
Jun 01 2018	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH	Director	Option Exercise	A	4.24	25,000	106,000	25,000
Jun 01 2018	ZSAN	Zosano Pharma Corp	Lewis Hayley	Senior VP, Operatio ...	Option Exercise	A	4.24	100,000	424,000	100,000
Jun 01 2018	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Option Exercise	A	4.24	100,000	424,000	100,000
Jun 01 2018	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	President and CEO	Option Exercise	A	4.27	100,000	427,000	100,000
Jun 01 2018	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	President and CEO	Option Exercise	A	4.24	300,000	1,272,000	300,000
May 21 2018	ZSAN	Zosano Pharma Corp	ELMS STEVE	Director	Option Exercise	A	4.27	25,000	106,750	25,000
Apr 27 2018	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Option Exercise	A	0.58	180,000	103,500	180,000
Apr 27 2018	ZSAN	Zosano Pharma Corp	Lewis Hayley	Senior VP, Operatio ...	Option Exercise	A	0.58	180,000	103,500	180,000
Mar 02 2018	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH	Director	Option Exercise	A	0.53	30,000	15,900	30,000
Mar 02 2018	ZSAN	Zosano Pharma Corp	WILSON TROY EDWARD	Director	Option Exercise	A	0.53	30,000	15,900	30,000
Mar 02 2018	ZSAN	Zosano Pharma Corp	Hagan Joseph P	Director	Option Exercise	A	0.53	30,000	15,900	30,000
Mar 02 2018	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G	Director	Option Exercise	A	0.53	30,000	15,900	30,000
Dec 08 2017	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH	Director	Buy	P	0.61	55,000	33,407	200,000	145 K to 200 K (+37.93 %)
Dec 04 2017	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH	Director	Buy	P	0.62	50,000	31,080	145,000	95 K to 145 K (+52.63 %)
Dec 04 2017	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH	Director	Buy	P	0.62	45,000	27,927	95,000	50 K to 95 K (+90.00 %)
Nov 16 2017	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH	Director	Buy	P	0.58	15,000	8,675	50,000	35 K to 50 K (+42.86 %)
Nov 16 2017	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH	Director	Buy	P	0.64	35,000	22,484	35,000	0 to 35 K
Oct 05 2017	ZSAN	Zosano Pharma Corp	GREATHOUSE KENNETH	Director	Option Exercise	A	0.84	60,000	50,400	60,000
Aug 11 2017	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	President and CEO	Option Exercise	A	0.99	300,000	297,000	300,000
Aug 11 2017	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	President and CEO	Sell	D	0.00	26,666	0	180,228	206.9 K to 180.2 K (-12.89 %)
May 25 2017	ZSAN	Zosano Pharma Corp	Erbez Georgia	CFO and Chief Busin ...	Buy	P	1.32	68,000	89,760	115,750	47.8 K to 115.8 K (+142.41 %)
May 25 2017	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Interim CEO	Buy	P	1.37	37,550	51,338	206,894	169.3 K to 206.9 K (+22.17 %)
May 25 2017	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Interim CEO	Buy	P	1.34	36,166	48,553	169,344	133.2 K to 169.3 K (+27.16 %)
May 22 2017	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Interim CEO	Grant	A	0.00	60,000	0	133,178	73.2 K to 133.2 K (+81.99 %)
May 08 2017	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Director	Option Exercise	M	0.00	9,478	0	0
May 08 2017	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Director	Buy	M	0.00	9,478	0	73,178	63.7 K to 73.2 K (+14.88 %)
Apr 12 2017	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Option Exercise	A	2.57	15,000	38,550	15,000
Apr 12 2017	ZSAN	Zosano Pharma Corp	Lewis Hayley	VP, Reg Affairs & Q ...	Option Exercise	A	2.57	15,000	38,550	15,000
Apr 12 2017	ZSAN	Zosano Pharma Corp	Tso Winnie Wing-Kei	Chief Financial Off ...	Option Exercise	A	2.57	3,500	8,995	17,500
Mar 22 2017	ZSAN	Zosano Pharma Corp	Alataris Konstantinos	President, CEO	Option Exercise	M	1.45	127,389	184,714	0
Mar 22 2017	ZSAN	Zosano Pharma Corp	Alataris Konstantinos	President, CEO	Buy	M	1.45	127,389	184,714	254,778	127.4 K to 254.8 K (+100.00 %)
Nov 04 2016	ZSAN	Zosano Pharma Corp	WILSON TROY EDWARD	Director	Option Exercise	A	0.58	20,000	11,500	20,000
Nov 04 2016	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G	Director	Option Exercise	A	0.58	20,000	11,500	20,000
Nov 04 2016	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Director	Option Exercise	A	0.58	30,000	17,250	30,000
Nov 04 2016	ZSAN	Zosano Pharma Corp	Hagan Joseph P	Director	Option Exercise	A	0.58	20,000	11,500	20,000
Sep 20 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	0.75	7,471	5,603	2,052,805	2.1 M to 2.1 M (-0.36 %)
Sep 20 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	0.75	7,471	5,603	2,052,805	2.1 M to 2.1 M (-0.36 %)
Sep 15 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	0.74	10,000	7,400	2,060,276	2.1 M to 2.1 M (-0.48 %)
Sep 15 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	0.74	10,000	7,400	2,060,276	2.1 M to 2.1 M (-0.48 %)
Sep 09 2016	ZSAN	Zosano Pharma Corp	Erbez Georgia	CBO and Interim CFO	Option Exercise	A	0.77	252,000	194,040	252,000
Aug 31 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	1.01	50,000	50,440	2,070,276	2.1 M to 2.1 M (-2.36 %)
Aug 31 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	1.01	50,000	50,440	2,070,276	2.1 M to 2.1 M (-2.36 %)
Aug 26 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	1.21	1,200	1,452	2,120,276	2.1 M to 2.1 M (-0.06 %)
Aug 26 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	1.21	1,200	1,452	2,120,276	2.1 M to 2.1 M (-0.06 %)
Aug 22 2016	ZSAN	Zosano Pharma Corp	Alataris Konstantinos	President, CEO	Option Exercise	P	1.55	127,389	197,453	127,389
Aug 22 2016	ZSAN	Zosano Pharma Corp	Alataris Konstantinos	President, CEO	Option Exercise	P	1.45	127,389	184,714	127,389
Aug 22 2016	ZSAN	Zosano Pharma Corp	Alataris Konstantinos	President, CEO	Buy	P	1.32	127,389	168,153	127,389	0 to 127.4 K
Aug 22 2016	ZSAN	Zosano Pharma Corp	Lewis Hayley	VP, Reg Affairs & Q ...	Option Exercise	P	1.55	4,775	7,401	4,775
Aug 22 2016	ZSAN	Zosano Pharma Corp	Lewis Hayley	VP, Reg Affairs & Q ...	Option Exercise	P	1.45	4,775	6,924	4,775
Aug 22 2016	ZSAN	Zosano Pharma Corp	Lewis Hayley	VP, Reg Affairs & Q ...	Buy	P	1.32	4,775	6,303	4,775	0 to 4.8 K
Aug 22 2016	ZSAN	Zosano Pharma Corp	Erbez Georgia	Interim CFO	Option Exercise	P	1.55	47,750	74,013	47,750
Aug 22 2016	ZSAN	Zosano Pharma Corp	Erbez Georgia	Interim CFO	Option Exercise	P	1.45	47,750	69,238	47,750
Aug 22 2016	ZSAN	Zosano Pharma Corp	Erbez Georgia	Interim CFO	Buy	P	1.32	47,750	63,030	47,750	0 to 47.8 K
Aug 22 2016	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Director	Option Exercise	P	1.55	63,700	98,735	63,700
Aug 22 2016	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Director	Option Exercise	P	1.45	63,700	92,365	63,700
Aug 22 2016	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Director	Buy	P	1.32	63,700	84,084	63,700	0 to 63.7 K
Aug 22 2016	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Option Exercise	P	1.55	15,920	24,676	15,920
Aug 22 2016	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Option Exercise	P	1.45	15,920	23,084	15,920
Aug 22 2016	ZSAN	Zosano Pharma Corp	KELLERMAN DONALD J	VP, Clinical Dev & ...	Buy	P	1.32	15,920	21,014	15,920	0 to 15.9 K
Aug 22 2016	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G	Director	Option Exercise	P	1.55	15,920	24,676	15,920
Aug 22 2016	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G	Director	Option Exercise	P	1.45	15,920	23,084	15,920
Aug 22 2016	ZSAN	Zosano Pharma Corp	XANTHOPOULOS KLEANTHIS G	Director	Buy	P	1.32	15,920	21,014	21,920	6 K to 21.9 K (+265.33 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	1.33	8,989	11,957	2,121,476	2.1 M to 2.1 M (-0.42 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	1.33	8,989	11,957	2,121,476	2.1 M to 2.1 M (-0.42 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	1.24	14,158	17,550	2,130,465	2.1 M to 2.1 M (-0.66 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	1.24	14,158	17,550	2,130,465	2.1 M to 2.1 M (-0.66 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	1.17	534	625	2,144,623	2.1 M to 2.1 M (-0.02 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	1.17	534	625	2,144,623	2.1 M to 2.1 M (-0.02 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	1.33	8,989	11,957	2,121,476	2.1 M to 2.1 M (-0.42 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	1.33	8,989	11,957	2,121,476	2.1 M to 2.1 M (-0.42 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	1.24	14,158	17,550	2,130,465	2.1 M to 2.1 M (-0.66 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	1.24	14,158	17,550	2,130,465	2.1 M to 2.1 M (-0.66 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	1.17	534	625	2,144,623	2.1 M to 2.1 M (-0.02 %)
Jul 21 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	1.17	534	625	2,144,623	2.1 M to 2.1 M (-0.02 %)
Jul 15 2016	ZSAN	Zosano Pharma Corp	BARRETT M JAMES	10% Owner	Sell	S	1.20	13,382	16,060	2,145,157	2.2 M to 2.1 M (-0.62 %)
Jul 15 2016	ZSAN	Zosano Pharma Corp	New Enterprise Associates 12, ...	10% Owner	Sell	S	1.20	13,382	16,060	2,145,157	2.2 M to 2.1 M (-0.62 %)
Jul 01 2016	ZSAN	Zosano Pharma Corp	Scharin Eric	VP, Engineering & O ...	Option Exercise	A	2.57	3,750	9,638	3,750
Jul 01 2016	ZSAN	Zosano Pharma Corp	Tso Winnie Wing-Kei	Chief Financial Off ...	Option Exercise	A	2.57	14,000	35,980	14,000
May 06 2016	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Director	Option Exercise	A	0.00	9,478	0	9,478
May 06 2016	ZSAN	Zosano Pharma Corp	WALKER JOHN PETER	Director	Option Exercise	A	2.11	6,813	14,375	6,813
Mar 30 2016	ZSAN	Zosano Pharma Corp	Tso Winnie Wing-Kei	Chief Financial Off ...	Option Exercise	A	2.57	15,000	38,550	15,000
Feb 04 2016	ZSAN	Zosano Pharma Corp	Alataris Konstantinos	President, CEO	Option Exercise	A	2.34	200,000	468,000	200,000
Dec 16 2015	ZSAN	Zosano Pharma Corp	Peri Laxmi	Sr. Vice President, ...	Option Exercise	A	2.26	40,000	90,400	40,000
Dec 16 2015	ZSAN	Zosano Pharma Corp	Peri Laxmi	Sr. Vice President, ...	Option Exercise	D	9.29	40,000	371,600	0
Dec 16 2015	ZSAN	Zosano Pharma Corp	Alataris Konstantinos	President	Option Exercise	A	2.26	209,394	473,230	209,394
Dec 16 2015	ZSAN	Zosano Pharma Corp	Alataris Konstantinos	President	Option Exercise	D	9.29	160,498	1,491,026	0
Dec 16 2015	ZSAN	Zosano Pharma Corp	Alataris Konstantinos	President	Option Exercise	D	9.29	48,896	454,244	0

Page: 1 2 next >